tiprankstipranks
Trending News
More News >
Hin Sang Group (International) Holding Co. Ltd. (HK:6893)
:6893
Hong Kong Market

Hin Sang Group (International) Holding Co. Ltd. (6893) AI Stock Analysis

Compare
0 Followers

Top Page

HK:6893

Hin Sang Group (International) Holding Co. Ltd.

(6893)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 4o)
Rating:49Neutral
Price Target:
HK$0.26
▼(-13.67% Downside)
The overall stock score is primarily impacted by the company's weak financial performance, characterized by ongoing losses and high leverage. While technical analysis shows positive momentum, the overbought indicators suggest caution. The negative P/E ratio and lack of dividend yield further weigh on the valuation score.
Positive Factors
Diversified Revenue Model
A diversified revenue model through multiple channels reduces dependency on any single source, enhancing resilience against market fluctuations.
Premium Pricing Strategy
Premium pricing can lead to higher profit margins, supporting long-term profitability if the brand maintains its perceived value.
Market Position in Health Sector
Positioning in the growing health and wellness sector aligns with increasing consumer focus on health, supporting long-term demand.
Negative Factors
High Leverage
High leverage can strain financial resources and limit flexibility, posing risks to long-term financial health and stability.
Negative Cash Flow
Negative cash flow indicates insufficient cash generation to cover losses, challenging the company's ability to sustain operations without external financing.
Ongoing Losses
Persistent losses and negative margins highlight operational inefficiencies, threatening long-term viability unless addressed.

Hin Sang Group (International) Holding Co. Ltd. (6893) vs. iShares MSCI Hong Kong ETF (EWH)

Hin Sang Group (International) Holding Co. Ltd. Business Overview & Revenue Model

Company DescriptionHin Sang Group (International) Holding Co. Ltd. is a Hong Kong-based company primarily engaged in the production and distribution of health food products, particularly focusing on traditional Chinese medicine and herbal products. The company operates in various sectors, including retail, wholesale, and e-commerce, providing a diverse range of products such as herbal teas, dietary supplements, and skincare items derived from natural ingredients.
How the Company Makes MoneyThe company generates revenue through multiple streams, including direct sales of its health food products across various retail channels, online sales through e-commerce platforms, and wholesale distribution to other retailers and businesses. Hin Sang Group also capitalizes on strategic partnerships with suppliers and distributors to enhance its market reach and product offerings. Additionally, the company may benefit from brand recognition and customer loyalty in the health and wellness sector, contributing to its overall earnings.

Hin Sang Group (International) Holding Co. Ltd. Financial Statement Overview

Summary
Hin Sang Group faces significant financial challenges, with ongoing losses and high leverage. Despite some revenue growth, profitability and cash flow management remain critical issues. The company needs to focus on improving operational efficiency and reducing debt to enhance financial stability.
Income Statement
35
Negative
Hin Sang Group has shown some revenue growth, but profitability remains a significant concern. The gross profit margin is relatively healthy, but the company has been consistently operating at a net loss, with negative EBIT and EBITDA margins. This indicates challenges in managing operational costs and achieving profitability.
Balance Sheet
40
Negative
The company's balance sheet reveals high leverage, with a debt-to-equity ratio above 2, indicating potential financial risk. The return on equity is negative, reflecting ongoing losses. However, the equity ratio is moderate, suggesting some stability in asset financing.
Cash Flow
30
Negative
Cash flow analysis shows negative free cash flow growth and a low operating cash flow to net income ratio, highlighting cash management issues. The free cash flow to net income ratio is significantly negative, indicating that the company is not generating sufficient cash from its operations to cover its losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue91.89M91.89M92.62M81.46M120.55M119.44M
Gross Profit60.28M60.28M57.41M38.84M69.08M68.79M
EBITDA-22.51M-16.57M-3.58M-17.05M21.82M-4.35M
Net Income-49.36M-49.36M-36.70M-49.49M-11.91M-31.95M
Balance Sheet
Total Assets555.73M555.73M587.85M618.28M693.77M711.82M
Cash, Cash Equivalents and Short-Term Investments19.87M19.87M19.35M12.44M17.58M18.05M
Total Debt344.41M344.41M321.10M318.42M320.91M345.50M
Total Liabilities399.61M399.61M378.52M378.37M391.97M392.24M
Stockholders Equity155.28M155.28M208.84M239.38M301.59M318.28M
Cash Flow
Free Cash Flow-4.27M-4.27M5.62M-3.79M23.65M-53.16M
Operating Cash Flow638.00K638.00K6.29M402.00K23.99M10.65M
Investing Cash Flow-4.73M-4.73M-585.00K-2.09M15.20M-63.72M
Financing Cash Flow6.27M6.27M-4.87M-93.00K-41.67M55.34M

Hin Sang Group (International) Holding Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.30
Price Trends
50DMA
0.22
Positive
100DMA
0.22
Positive
200DMA
0.20
Positive
Market Momentum
MACD
<0.01
Negative
RSI
81.37
Negative
STOCH
64.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6893, the sentiment is Positive. The current price of 0.3 is above the 20-day moving average (MA) of 0.25, above the 50-day MA of 0.22, and above the 200-day MA of 0.20, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 81.37 is Negative, neither overbought nor oversold. The STOCH value of 64.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:6893.

Hin Sang Group (International) Holding Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
HK$286.40M12.175.51%6.70%-34.28%-45.72%
66
Neutral
HK$373.77M6.3110.92%11.10%-4.38%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
HK$286.12M9.533.77%10.32%-6.67%-29.55%
56
Neutral
HK$615.65M20.323.92%-0.92%-71.88%
49
Neutral
HK$260.94M-8.17-23.55%10.42%11.14%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6893
Hin Sang Group (International) Holding Co. Ltd.
0.30
0.04
15.38%
HK:1455
Fourace Industries Group Holdings Limited
0.23
0.09
62.86%
HK:1962
Evergreen Products Group Ltd.
0.46
0.04
9.52%
HK:2023
China Ludao Technology Co. Ltd.
0.73
-0.17
-18.89%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.38
-0.20
-34.48%

Hin Sang Group (International) Holding Co. Ltd. Corporate Events

Hin Sang Group Reports Improved Financial Performance Despite Losses
Nov 27, 2025

Hin Sang Group (International) Holding Co. Ltd. reported its interim results for the six months ended 30 September 2025, showing a revenue increase of 7.9% to HK$49,857,000 and a gross profit rise of 13.3% to HK$34,004,000 compared to the same period in 2024. Despite these improvements, the company recorded a loss of HK$9,841,000, which is a 48.9% reduction in loss compared to the previous year, indicating a positive trend in financial performance.

Hin Sang Group Projects Significant Reduction in Net Loss
Nov 17, 2025

Hin Sang Group (International) Holding Co. Ltd. announced an expected decrease in its consolidated net loss by over 47% for the six months ended 30 September 2025, compared to the same period in 2024. This improvement is attributed to increased gross profit due to enhanced cost containment measures and a reduction in administrative and operating expenses, including staff costs and legal fees. The final unaudited results are pending and will be released on 27 November 2025, with stakeholders advised to exercise caution.

Hin Sang Group Schedules Board Meeting for Interim Results Review
Nov 13, 2025

Hin Sang Group (International) Holding Co. Ltd. has announced that its board of directors will convene on November 27, 2025, to review and approve the company’s unaudited interim results for the six months ending September 30, 2025. The meeting will also consider the possibility of declaring an interim dividend. This announcement is part of the company’s compliance with the listing rules of the Hong Kong Stock Exchange.

Hin Sang Group’s AGM Resolutions Unanimously Approved
Sep 25, 2025

Hin Sang Group (International) Holding Co. Ltd. announced that all proposed resolutions at its annual general meeting held on September 25, 2025, were unanimously approved by shareholders. This includes the re-election of directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of mandates for share repurchase and issuance, indicating strong shareholder support and potentially enhancing the company’s operational flexibility and strategic positioning.

Hin Sang Group AGM Rescheduling Due to Weather Concerns
Sep 22, 2025

Hin Sang Group (International) Holding Co. Ltd. has announced potential changes to its Annual General Meeting (AGM) schedule due to the approach of a tropical cyclone in Hong Kong. If severe weather conditions persist, the AGM originally set for 25 September 2025 will be rescheduled to 29 September 2025. All resolutions and proxy arrangements will remain unchanged, and shareholders are advised to exercise caution if attending under adverse weather conditions.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 28, 2025